Perspective Insight into Future Potential Fusion Gene Transcript Biomarker Candidates in Breast Cancer

Next generation sequencing has accelerated the discovery of a variety of new fusion gene types in clinical breast cancer samples by analyzing cancer genomes and transcriptomes. Although previous studies have focused on a few clinically validated oncogenic fusion genes as diagnostic and therapeutic t...

Full description

Bibliographic Details
Main Authors: Ryong Nam Kim, Hyeong-Gon Moon, Wonshik Han, Dong-Young Noh
Format: Article
Language:English
Published: MDPI AG 2018-02-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:http://www.mdpi.com/1422-0067/19/2/502
id doaj-35bfe8a61302434c86b282754bdcfea5
record_format Article
spelling doaj-35bfe8a61302434c86b282754bdcfea52020-11-24T20:47:13ZengMDPI AGInternational Journal of Molecular Sciences1422-00672018-02-0119250210.3390/ijms19020502ijms19020502Perspective Insight into Future Potential Fusion Gene Transcript Biomarker Candidates in Breast CancerRyong Nam Kim0Hyeong-Gon Moon1Wonshik Han2Dong-Young Noh3Center for Medical Innovation, Biomedical Research Institute, Seoul National University Hospital, Seoul 03080, KoreaDepartment of Surgery, Seoul National University College of Medicine, Seoul 03080, KoreaDepartment of Surgery, Seoul National University College of Medicine, Seoul 03080, KoreaDepartment of Surgery, Seoul National University College of Medicine, Seoul 03080, KoreaNext generation sequencing has accelerated the discovery of a variety of new fusion gene types in clinical breast cancer samples by analyzing cancer genomes and transcriptomes. Although previous studies have focused on a few clinically validated oncogenic fusion genes as diagnostic and therapeutic targets in breast cancer, a perspective consideration has not been given thus far for a plethora of breast cancer fusion genes, which are being newly identified at an overwhelmingly increasing pace. In this perspective review, we discuss diverse fusion gene types recently identified in a variety of breast cancer subtypes, including breast clinical cancer samples in TCGA (The Cancer Genome Atlas) database. This perspective review will confer fresh and promising guidance onto breast cancer surgeons, clinical oncologists, and tumor biologists in determining research directions for seeking and developing novel fusion gene biomarkers for breast cancer diagnostics and therapeutic treatment in upcoming years.http://www.mdpi.com/1422-0067/19/2/502fusion gene transcriptbreast cancerbiomarker
collection DOAJ
language English
format Article
sources DOAJ
author Ryong Nam Kim
Hyeong-Gon Moon
Wonshik Han
Dong-Young Noh
spellingShingle Ryong Nam Kim
Hyeong-Gon Moon
Wonshik Han
Dong-Young Noh
Perspective Insight into Future Potential Fusion Gene Transcript Biomarker Candidates in Breast Cancer
International Journal of Molecular Sciences
fusion gene transcript
breast cancer
biomarker
author_facet Ryong Nam Kim
Hyeong-Gon Moon
Wonshik Han
Dong-Young Noh
author_sort Ryong Nam Kim
title Perspective Insight into Future Potential Fusion Gene Transcript Biomarker Candidates in Breast Cancer
title_short Perspective Insight into Future Potential Fusion Gene Transcript Biomarker Candidates in Breast Cancer
title_full Perspective Insight into Future Potential Fusion Gene Transcript Biomarker Candidates in Breast Cancer
title_fullStr Perspective Insight into Future Potential Fusion Gene Transcript Biomarker Candidates in Breast Cancer
title_full_unstemmed Perspective Insight into Future Potential Fusion Gene Transcript Biomarker Candidates in Breast Cancer
title_sort perspective insight into future potential fusion gene transcript biomarker candidates in breast cancer
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1422-0067
publishDate 2018-02-01
description Next generation sequencing has accelerated the discovery of a variety of new fusion gene types in clinical breast cancer samples by analyzing cancer genomes and transcriptomes. Although previous studies have focused on a few clinically validated oncogenic fusion genes as diagnostic and therapeutic targets in breast cancer, a perspective consideration has not been given thus far for a plethora of breast cancer fusion genes, which are being newly identified at an overwhelmingly increasing pace. In this perspective review, we discuss diverse fusion gene types recently identified in a variety of breast cancer subtypes, including breast clinical cancer samples in TCGA (The Cancer Genome Atlas) database. This perspective review will confer fresh and promising guidance onto breast cancer surgeons, clinical oncologists, and tumor biologists in determining research directions for seeking and developing novel fusion gene biomarkers for breast cancer diagnostics and therapeutic treatment in upcoming years.
topic fusion gene transcript
breast cancer
biomarker
url http://www.mdpi.com/1422-0067/19/2/502
work_keys_str_mv AT ryongnamkim perspectiveinsightintofuturepotentialfusiongenetranscriptbiomarkercandidatesinbreastcancer
AT hyeonggonmoon perspectiveinsightintofuturepotentialfusiongenetranscriptbiomarkercandidatesinbreastcancer
AT wonshikhan perspectiveinsightintofuturepotentialfusiongenetranscriptbiomarkercandidatesinbreastcancer
AT dongyoungnoh perspectiveinsightintofuturepotentialfusiongenetranscriptbiomarkercandidatesinbreastcancer
_version_ 1716810700871958528